HII PsiQuantum Series I, a Series of HII PsiQuantum, LLC
Raised
$1M
Investors
37
Min Invest
$25,000
AltStreet Analysis
·Generated from EDGAR primary sources
HII PsiQuantum Series I, a Series of HII PsiQuantum, LLC is a pooled investment fund entity filed under Rule 506(b) and Section 3(c)(1) exemptions, raising $1.4M from 37 investors with a $25K minimum investment. The filing, dated August 19, 2025, is managed by Manasi Vydyanath and operates as part of the Hiive platform ecosystem, which has 69 related EDGAR entities primarily focused on single-company SPV offerings including multiple Anthropic series vehicles.
This offering represents a relatively accessible private equity investment with a $25K minimum, significantly lower than traditional fund minimums ($100K+). The 506(b) exemption limits marketing to pre-existing relationships, while the 3(c)(1) exemption caps the vehicle at 100 beneficial owners, consistent with single-company SPV structures commonly used for pre-IPO equity access.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Manasi Vydyanath
Executive Officer · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
